Stocks in Play - August 5th 2025

Stocks in Play: SNDX, SMXT, AXON, AIP

Stocks in Play - August 5th 2025

Stocks in Play: SNDX, SMXT, AXON, AIP

Welcome to today's Stocks in Play report. Below are the key stocks to watch, along with brief x-ray and analysis.

If you find this Newsletter helpful and ever want to say thank you then feel free to Buy Me a Coffee. It’ll inspire me to work faster….

I use Benzinga Pro (Essential) for 90% of my research each day. I have recently subscribed to a LIFETIME subscription for $1650. This is incredible value. If this is something you’d be interested in then shoot me an email ([email protected]) and I’ll put you in touch with the Rep to receive the agreed price. I couldn’t recommend it highly enough.

1) Syndax Pharmaceuticals (SNDX) (Rating: B+, Multi-Day)

X-Ray SNDX: Industry Group: Biotechnology, Market Cap: 893.17M, Float: 82.48M Short Interest 28.72%, Days to Cover: 10.49, Exchange: NASDAQ

Revs up 986% YoY after first Full Quarter launches of Revuforj and Nikimvo oncology products. Losses narrowed, Strong cash position and Beat on EPS & Revs. Very neglected. Company is transitioning into a rev generating oncology company. High short interest, reasonable float. Chart has room up to $14 where it hits a wall. Though analyst upgrades are targeting prices much higher. As seen below. Note this is a Biotech so careful on size and swings.

SNDX Analyst Targets are diverging massively from current price.

2) Arteris Inc. (AIP) (Rating: B+, Multi-Day)

X-Ray AIP: Industry Group: Semiconductors, Market Cap: 396.69M, Float: 27.55M Short Interest 3.42%, Days to Cover: 1.92, Exchange: NASDAQ

AMD Licenses Arteris FlexGen NoC IP For Next-Gen AI Chiplets To Boost Performance Across Data Center To Edge Devices. This is a major win for AIP. However, no finances have been shared and they have earnings tonight. I would be quite wary that this has been announced the day before earnings. There will likely now be expectation for a Guide beat if that doesn’t occur the stock could give up it’s gains. Note also AMD are reporting tonight. Good SIP today and potential for delayed reaction tomorrow if earnings exceed expectation.

Honorable Mention to:

AXON: Strong beat on EPS ($2.12 vs est. $1.46), Solid Beat on Revs (+33% YoY), All KPIs are strong - Software & Services 39%, Connected Devices 29%, Platforms Solutions (which includes Counter Drone Tech) up $86% YoY. ARR now makes up 50% of Revs, which is a huge successful transition from Hardware to Software and subscription revs. AI Winner and in Theme with Drones. Stock is certainly not neglected but nice potential to break out here above ATH. High Priced Stock.

X-Ray AXON: Industry Group: Aerospace & Defense, Market Cap: 57.99B, Float: 73.66M Short Interest 2.08%, Days to Cover: 2.49, Exchange: NASDAQ

SMXT: $127.3 million EPC contract for a 430 MWh utility-scale battery storage project in Texas with Longfellow BESS I LLC. The company will also acquire an 8% equity stake in the project. SolarMax’s first major commercial-scale deal in the U.S., signaling a shift from its residential solar roots into high-value EPC contracts. Project completion is targeted for June 30, 2026. Neglected, Microcap. Strong EP Candidate. Will likely do a significant stock offering AH.

X-Ray SMXT: Industry Group: Solar, Market Cap: 44.09M, Float: 29.40M Short Interest 0.62%, Days to Cover: 1.28, Exchange: NASDAQ

Delayed Reaction Watchlist: TradingView

Market Awareness

Super strong rebound yesterday. Softer gap up this morning. Strong earnings from Growth stocks. Bullish overall but expect some choppiness today after such a big few days. Still cautious on new risk and peeling faster until I am confident we are seeing more follow through. AMD will be big for Semis tonight.

Sources & Services I Use in my Trading:

PS: There are many ways to trade stocks in play. It does not have to be the one that keeps going straight up and sometimes it doesn’t even have to be day one of the catalyst. Everyone must find a setup, timeframe and method that works for them. This list is supposed to educate on the criteria I use and the methods in which I find Stocks in Play. Yours may differ and that is completely okay.

Reply

or to participate.